Riskpilot← Back to searchSign inGet full accessResund Behandling AB
ABActiveOrg 5590379094Talltitevägen 34Medical specialists activities · NACE 8622Est. 201511 employees
Revenue 2024
SEK 19,6M
+29% vs 2023
EBITDA margin
30.8%
+172% vs 2023
Equity ratio
43.4%
Financial strength
Net profit 2024
SEK 3,8M
+70% vs 2023
| Revenue | SEK 19,6M | +29% |
| EBITDA | SEK 6M | +172% |
| Net profit | SEK 3,8M | +70% |
| Total assets | SEK 10,5M | +65% |
| Equity | SEK 4,5M | +73% |
| Employees | 11 | — |
Legal name
Resund Behandling AB
Org number
5590379094
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 december 2015
Share capital
SEK 60 000
Employees
11 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Specialiserad psykiatrisk bedömning och behandling samt förenlig verksamhet såsom tex utbildning och handledning.
Address
Talltitevägen 34
Email
resundbehandling@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 630 | 13 076 | 13 776 | 15 235 | 19 635 |
| Staff expenses | — | — | −7 471 | −7 539 | −9 769 |
| EBITDA | 2 830 | 1 850 | 3 344 | 2 225 | 6 041 |
| Depreciation & amort. | −30 | −23 | — | −30 | −161 |
| EBIT | 2 800 | 1 827 | 3 344 | 2 195 | 5 880 |
| Net financials | −48 | −2 | −0 | 66 | 41 |
| Profit before tax | 2 072 | 1 385 | 3 343 | 2 797 | 4 766 |
| Tax | −449 | −290 | −695 | −589 | −1 005 |
| Net profit | 1 623 | 1 095 | 2 648 | 2 208 | 3 761 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 042 | 6 738 | 8 413 | 6 337 | 10 463 |
| Equity | 2 075 | 2 070 | 3 419 | 2 626 | 4 537 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 610 | 1 872 | 2 198 | 1 631 | 2 735 |
| Total debt | 610 | 1 872 | 2 198 | 1 631 | 2 735 |
EBITDA margin
30.8%
This company
15.8%
Market median
+95% vs market
20202024
Equity ratio
43.4%
This company
38.2%
Market median
+14% vs market
20202024
Return on equity
82.9%
This company
18.4%
Market median
+351% vs market
20202024
Net profit margin
19.2%
This company
8.1%
Market median
+137% vs market
20202024
Asset turnover
1.88×
This company
1.12×
Market median
+68% vs market
20202024
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LJ Audit | Audit | 2022 |
IF Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
TA Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Resund Behandling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tove Anna Ida Unosson Kortelainen | Chief Auditor | 0 companies |
| Lars Joakim Leifland | Audit | 0 companies |
| Ingrid Faye Joan Holmquist | Chief Executive Officer | 0 companies |
| Carl Edvard Holmquist | Deputy Board Member | 0 companies |
| Daniel Stefan Robert Lundstam | Deputy Board Member | 0 companies |
| Johanna Faye Lundstam | Board of Directors | 0 companies |
| Sten Hugo Carlsson | Deputy Board Member | 0 companies |
| Karin Sofia Margareta Olsson | Chairman | 0 companies |